39628-26-7

Basic information

• Product Name: N-(3,4-Dimethoxy-β-phenylaethyl)-acetoxyacetamid
• Synonyms: N-(3,4-Dimethoxy-β-phenylaethyl)-acetoxyacetamid
• CAS NO: 39628-26-7
• Molecular Weight: 281.309
• Mol File: 39628-26-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(3,4-Dimethoxy-β-phenylaethyl)-acetoxyacetamid(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3,4-Dimethoxy-β-phenylaethyl)-acetoxyacetamid(39628-26-7)
• EPA Substance Registry System: N-(3,4-Dimethoxy-β-phenylaethyl)-acetoxyacetamid(39628-26-7)

Safety Data

• Hazardous Substances Data: 39628-26-7(Hazardous Substances Data)

Upstream product

• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 39220-86-5 2-nitro-1-(3,4-dimethoxyphenyl)ethanol 
• 56997-75-2 N-(3,4-dimethoxyphenethyl)-α-bromoacetamide 
• 64-19-7 acetic acid 

Relevant articles and documents

Designing new analogs for streamlining the structure of cytotoxic lamellarin natural products

Despite the therapeutic potential of marine-derived lamellarin natural products, their preclinical development has been hampered by their lipophilic nature, causing very poor aqueous solubility. In order to develop more drug-like analogs, their structure was streamlined in this study from both the cytotoxic activity and lipophilicity standpoints. First, a modified total synthetic route was successfully devised to construct a library of 59 systematically designed lamellarin analogs, which were then subjected to cytotoxicity and log P determinations. Along with the 25 first-generation lamellarins previously synthesized in our laboratory, the structure-activity and structure-lipophilicity relationships were extensively evaluated. Our results clearly indicated the additional structural requirements around the lamellarin skeleton which, when combined with those reported previously, can provide invaluable guidance for further modifications to increase the aqueous solubility of these compounds.